Blue Cure

BlueCure is an Israel-based medical technology company focused on developing a novel, minimally invasive treatment for prostate cancer. The company's primary innovation is a localized therapy designed to treat cancerous tissue while preserving surrounding healthy structures and minimizing side effects common in traditional treatments. By utilizing advanced energy-based ablation or targeted delivery mechanisms, BlueCure aims to provide a more precise alternative to radical prostatectomy or radiation. The company is currently advancing its technology through pre-clinical validation and early-stage development to address the significant unmet need in localized prostate cancer management.